Curious about what's happening in today's session? Check out the latest stock movements and price changes.
By Mill Chart
Last update: Mar 22, 2024
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Gainers
| Ticker | Change | Comment |
|---|---|---|
| BCAN | 12.0K% | Exciting news for BYND CANNASOFT ENTERPRISES (NASDAQ:BCAN) as its stock price surged 12.0K% to $2.44 during Friday's session. In the last month the share price dropped with 90.54%. |
| MBRX | 1.0K% | MOLECULIN BIOTECH INC (NASDAQ:MBRX) rose 1.0K% to $5.8 during Friday's after hours session. Shareholders saw the stock price going 35.0% lower in the past 3 months. |
| ATER | 1.0K% | ATERIAN INC (NASDAQ:ATER) witnessed a notable 1.0K% uptick in its shares, reaching $3.28 during Friday's session. In the last month the stock lost 26.77%. |
| MLGO | 791.0% | Exciting news for MICROALGO INC (NASDAQ:MLGO) as its stock price surged 791.0% to $3.83 during Friday's session. In the last month the share price dropped with 44.81%. |
| CGC | 45.18% | CANOPY GROWTH CORP's (NASDAQ:CGC) stock price is advancing with 45.18% to a price of $6.62. In the last month the stock gained 35.31%. |
| OTRK | 38.46% | Investors witnessed a remarkable 38.46% rise in ONTRAK INC's (NASDAQ:OTRK) shares, which climbed to $0.36 during Friday's session. A press release (Ontrak Health Announces the Launch of the Ontrak Advanced Engagement System, Ushering in the Next Era of AI-enabled Behavioral Healthcare) was released yesterday. |
| VIRI | 33.98% | VIRIOS THERAPEUTICS INC (NASDAQ:VIRI) witnessed a notable 33.98% uptick in its shares, reaching $0.44 during Friday's session. Shareholders saw the stock price going 44.43% lower in the past 3 months. |
| OTLK | 32.1% | OUTLOOK THERAPEUTICS INC's (NASDAQ:OTLK) stock price displayed strong growth, advancing 32.1% and reaching $9.3 during Friday's session. In the last 6 months the stock gained 68.5%. |
| VERI | 31.88% | Positive market sentiment drove VERITONE INC's (NASDAQ:VERI) stock price up by 31.88% to $4.84 during Friday's session. In the last month the share price increased with 88.69%. |
| IMCC | 30.57% | IM CANNABIS CORP's (NASDAQ:IMCC) shares rose 30.57% to $0.38 during Friday's session. Shareholders saw the stock price going 49.96% lower is the past 6 months. |
To see the full list of top gainers you can use our top gainers page.
Top losers
| Ticker | Change | Comment |
|---|---|---|
| SINT | -30.07% | There was a downturn in SINTX TECHNOLOGIES INC's (NASDAQ:SINT) shares, as they experienced a 30.07% decline, closing at $0.1 during Friday's session. In the last 3 months the stock lost 71.06%. |
| NKTX | -29.66% | NKARTA INC's (NASDAQ:NKTX) shares fell 29.66% to $9.13. In the last month the share price increased with 36.63%. |
| CUTR | -27.85% | Investors witnessed a 27.85% decrease in CUTERA INC's (NASDAQ:CUTR) stock price, which closed at $1.66 during Friday's session. Yesterday the company had a press release: Cutera Announces Fourth Quarter and Full-Year 2023 Financial Results Along with 2024 Outlook. |
| RETO | -23.53% | The market experienced a 23.53% downturn in RETO ECO-SOLUTIONS INC's (NASDAQ:RETO) stock price, closing at $1.43 during Friday's session. Two days ago the company had a press release: ReTo Regained Compliance with Nasdaq's Minimum Bid Price Requirement and Received Extension on Compliance with Nasdaq's Minimum Stockholders' Equity Rule. |
| SWVL | -22.14% | SWVL HOLDINGS CORP's (NASDAQ:SWVL) stock price is declining with 22.14% to a price of $11.29. In the last month the share price increased with 223.0%. |
| GNS | -22.12% | GENIUS GROUP LTD's (NYSEARCA:GNS) stock price is declining with 22.12% to a price of $0.41. In the last month the share price increased with 51.25%. |
| SOUNW | -21.57% | Investors witnessed a 21.57% decrease in SOUNDHOUND AI INC's (NASDAQ:SOUNW) stock price, which closed at $2.69 during Friday's session. The stock is trading 29.43% higher than a month ago. |
| ATNF | -20.4% | 180 LIFE SCIENCES CORP's (NASDAQ:ATNF) shares fell 20.4% to $2.77. In the last 6 months the stock lost 67.91%. |
| ZURA | -19.72% | Investors witnessed a 19.72% decrease in ZURA BIO LTD's (NASDAQ:ZURA) stock price, which closed at $2.32 during Friday's session. Shareholders saw the stock price going 21.04% lower in the past month. |
| SGMO | -16.92% | SANGAMO THERAPEUTICS INC's (NASDAQ:SGMO) stock price is declining with 16.92% to a price of $0.81. Earlier today the company had a press release: Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering. |
For the full top loser list go to our top losers page.
OUTLOOK THERAPEUTICS INC
NASDAQ:OTLK (4/26/2024, 7:08:27 PM)
After market: 8.31 -0.12 (-1.42%)8.43
+0.24 (+2.93%)
OTLK News
ISELIN, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first...
13 days ago - InvestorPlaceBiotech on a Budget: 7 Stocks Under $10 With Huge PotentialWith the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks.
Positive opinion serves as a basis for final decision for potential authorization from the European Commission (EC), expected within 67 days ISELIN, N.J.,...
ISELIN, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab for the treatment of retinal diseases in the US and the EU, today announced that it has closed its previously announced private placement, for upfront gross proceeds of approximately $60 million from the issuance and sale of shares of the Company’s common stock and accompanying warrants, before deducting placement agent fees and offering expenses. Outlook Therapeutics has the potential to receive additional gross proceeds of up to $99 million upon the full cash exercise of the warrants issued in the private placement, before deducting placement agent fees and offering expenses.
ISELIN, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK) (the “Company”), a biopharmaceutical company working to...
2 months ago - InvestorPlace7 of the Best Speculative Stocks You Can Snag for Less Than $1Although speculative stocks under $1 are by their very nature extremely risky, these ideas might have enough to go the distance.
2 months ago - InvestorPlace7 Biotech Penny Stocks on the Verge of Clinical Trial VictoryBiotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money.
2 months ago - Seeking AlphaOutlook Therapeutics stock climbs 13% amid Chardan upgrade (NASDAQ:OTLK)Shares of Outlook Therapeutics (OTLK) climbed 13% after Chardan upgraded the stock to buy, citing the company’s recent private placement and the full cash exerc
NORSE EIGHT underway with first subject dosed and additional clinical sites beginning enrollment Continue to expect planned resubmission of the ONS-5010...
NORSE EIGHT clinical trial is being conducted under Special Protocol Assessment (SPA) from FDA to support expected resubmission of the ONS-5010 Biologics...
